266 related articles for article (PubMed ID: 11521528)
1. [Chronic aluminum intoxication in patients with terminal kidney failure on programmed hemodialysis (literature review)].
Milovanova LIu; Nikolaev AIu; Barashkov GK
Ter Arkh; 2001; 73(6):67-9. PubMed ID: 11521528
[No Abstract] [Full Text] [Related]
2. [Unusual course of renal osteopathy with Paget's disease and aluminum deposits].
Ringe JD; Delling G
Dtsch Med Wochenschr; 1985 Mar; 110(11):411-5. PubMed ID: 3979272
[TBL] [Abstract][Full Text] [Related]
3. Management of bone disease in the dialysis patient.
Crooks PW; Coburn JW
Blood Purif; 1985; 3(1-3):27-41. PubMed ID: 3913448
[TBL] [Abstract][Full Text] [Related]
4. Dialysis osteomalacia and aluminum toxicity: a form of renal osteodystrophy.
Felsenfeld AJ
ANNA J; 1985 Jun; 12(3):189-91. PubMed ID: 3848318
[No Abstract] [Full Text] [Related]
5. Recognition and management of aluminum intoxication in children.
Tsuru N; Williams JL; Chan JC
Int J Pediatr Nephrol; 1987; 8(3):177-86. PubMed ID: 3323095
[TBL] [Abstract][Full Text] [Related]
6. Aluminum in chronic hemodialysis. Possible influence on osteomalacic bone disease.
Quarello F; Giachino G; Bossi P; Gilli G; Corrao G; Scursatone E; Jeantet A; Bossi R; Coppo R; Piccoli G; Vercellone A
Minerva Nefrol; 1980; 27(4):635-44. PubMed ID: 7254691
[No Abstract] [Full Text] [Related]
7. Aluminum and renal osteodystrophy in chronic uremia.
Berland Y; Grandvuillemin M; Charhon S; Olmer M
Kidney Int Suppl; 1985 Dec; 17():S183-7. PubMed ID: 3867793
[No Abstract] [Full Text] [Related]
8. [Long-term treatment of secondary hyperparathyroidism in the chronic hemodialysis patient with 1,25-(OH)2D3].
Giachino G; Giacchino F; Jeantet A; Del Piano A; Garetto A; Pellerey M; Piccoli G
Minerva Med; 1985 Mar; 76(9-10):407-14. PubMed ID: 2984605
[No Abstract] [Full Text] [Related]
9. Desferrioxamine therapy in hemodialysis patients with aluminum-associated bone disease.
Felsenfeld AJ; Rodriguez M; Coleman M; Ross D; Llach F
Kidney Int; 1989 Jun; 35(6):1371-8. PubMed ID: 2770115
[TBL] [Abstract][Full Text] [Related]
10. [The role of aluminum in the human body].
Strzałkowska D
Postepy Hig Med Dosw; 1991; 45(3-4):257-79. PubMed ID: 1946095
[TBL] [Abstract][Full Text] [Related]
11. Aluminium poisoning: dialysis encephalopathy, osteomalacia, and anaemia.
Wills MR; Savory J
Lancet; 1983 Jul; 2(8340):29-34. PubMed ID: 6134894
[No Abstract] [Full Text] [Related]
12. Indirect methods for the diagnosis of aluminum bone disease: plasma aluminum, the desferrioxamine infusion test, and serum iPTH.
Nebeker HG; Andress DL; Milliner DS; Ott SM; Alfrey AC; Slatopolsky EA; Sherrard DJ; Coburn JW
Kidney Int Suppl; 1986 Feb; 18():S96-9. PubMed ID: 3458006
[No Abstract] [Full Text] [Related]
13. [Osteodystrophy and calcinosis in chronic renal failure treated by repeated hemodialysis].
Bagon J; Brunfaut C
J Radiol Electrol Med Nucl; 1974 Jan; 55(1):35-9. PubMed ID: 4831994
[No Abstract] [Full Text] [Related]
14. [Osteodystrophy in patients with chronic kidney insufficiency].
Ermolenko VM; Nikiforsva NV
Urol Nefrol (Mosk); 1970; 35(5):57-63. PubMed ID: 4929738
[No Abstract] [Full Text] [Related]
15. Parathyroid hormone in aluminum bone disease: a comparison of parathyroid hormone assays.
Andress DL; Endres DB; Ott SM; Sherrard DJ
Kidney Int Suppl; 1986 Feb; 18():S87-90. PubMed ID: 3458004
[No Abstract] [Full Text] [Related]
16. [Aluminum toxicity in patients with chronic renal failure].
Wanic-Kossowska M; Grzegorzewska A; Płotast H
Przegl Lek; 1995; 52(12):603-5. PubMed ID: 8834660
[No Abstract] [Full Text] [Related]
17. Parathyroid glands in chronic aluminum intoxication.
Cournot-Witmer G; Plachot JJ
Ultrastruct Pathol; 1990; 14(3):211-9. PubMed ID: 2356587
[TBL] [Abstract][Full Text] [Related]
18. The interaction of parathyroid hormone and aluminum in renal osteodystrophy.
Slatopolsky E
Kidney Int; 1987 Mar; 31(3):842-54. PubMed ID: 3573543
[No Abstract] [Full Text] [Related]
19. [Renal osteodystrophy (3); its treatment in dialysis patients].
Ghitu S; Oprisiu R; Benamar L; Said S; Tataru Albu A; Arsenescu I; el Esper N; Morinière P; Fournier A
Nephrologie; 2000; 21(8):413-24. PubMed ID: 11213385
[TBL] [Abstract][Full Text] [Related]
20. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis.
Coburn JW
Kidney Int Suppl; 1993 Feb; 40():S92-100. PubMed ID: 8445845
[No Abstract] [Full Text] [Related]
[Next] [New Search]
